Overview

Pravastatin and Protease Inhibitors in HIV-Infected Patients

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
To assess the use of pravastatin in hypercholesterolemic HIV-infected patients treated with protease inhibitors in a randomised double blind study.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Bordeaux
Collaborator:
Ministry of Health, France
Treatments:
HIV Protease Inhibitors
Pravastatin
Protease Inhibitors